Categories: HealthcareNews

Reliant Specialty Infusion Partners with Tennr to Scale and Accelerate Patient Access

NEW YORK, April 16, 2025 /PRNewswire/ — Tennr, the intelligent automation platform for healthcare operations, has announced a strategic partnership with Reliant Specialty Infusion as the infusion provider scales aggressively to meet growing patient demand. With Tennr’s advanced automation capabilities, Reliant Specialty Infusion aims to increase the speed of its insurance verification processes and significantly reduce script-to-seat turnaround times across its expanding network of locations.

The rising prevalence of chronic diseases, advancements in biologic therapies, and shifts in payor policies favoring outpatient settings are driving the expansion of infusion services. As infusion providers scale to meet these needs, operational efficiency has become essential to ensuring timely patient access to care.

“As we scale, maintaining speed and efficiency in our operations is critical,” said Kim Foret, CFO at Reliant Specialty Infusion. “Tennr’s automation technology is a game changer because we’re finally able to have efficient scalability without sacrificing the high-quality, timely care we’re known for.”

“Reliant’s growth is a testament to the quality care they provide,” said Trey Holterman, CEO at Tennr. “And Tennr is all about helping providers give fast, high quality care, so we’re excited to be the solution that’ll complement their dedication to expanding access to specialty infusion services.” 

Reliant Specialty Infusion is a leading provider of specialty infusion services, dedicated to delivering patient-centered care. They have 12 locations across Louisiana, Texas and Oklahoma and plan to continue their expansion in the future.

Tennr is a New York City-based healthcare technology company dedicated to eliminating patient delays throughout the U.S. healthcare system. Founded by Stanford AI Lab and Y Combinator alumni, Tennr has raised over $60M from investors including Andreessen Horowitz (a16z) and Lightspeed Venture Partners. The company’s intelligent automation platform accelerates patient throughput, helping healthcare providers deliver more timely and effective care without adding resources.

For more information, please visit https://www.tennr.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/reliant-specialty-infusion-partners-with-tennr-to-scale-and-accelerate-patient-access-302429448.html

SOURCE Tennr

Staff

Recent Posts

CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities

Houston, Texas--(Newsfile Corp. - December 22, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) (CBIH) announces…

47 minutes ago

XRP Healthcare® Secures Global Trademark Protection at the Intersection of Healthcare Services and XRP-Powered Payments

Multi-jurisdiction trademark coverage reinforces XRP Healthcare's position across digital health, pharmacy networks, and XRP-based payment…

2 hours ago

Black Book Poll: “Governed AI” Emerges as the Deciding Factor in 2026 NHS Procurement

Respondents report approvals and evaluation readiness are now the bottlenecks driving demand for reusable safety…

2 hours ago

Hemogenyx Pharmaceuticals PLC Announces Update on Admission of Shares

LONDON, UK / ACCESS Newswire / December 22, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the…

2 hours ago

What Is the Best GLP-1 Supplement for Weight Loss? Industry Analysis Reveals Probiotic Akkermansia Formulas as Affordable Ozempic Alternatives

Health Journey Addresses 'Best GLP-1 Supplement' Question with Akkermansia-Based Formula Analysis as Six-Month Costs Compare…

23 hours ago